Patient-Reported OUTcomes of Benralizumab in Real-World Use in Severe EosiNophilic Asthma Patients
NCT05603845
·
clinicaltrials.gov ↗
COMPLETED
Status
291
Enrollment
INDUSTRY
Sponsor class
Conditions
Severe Asthma
Sponsor
AstraZeneca